» Articles » PMID: 3415435

Preliminary Evidence on Metabolic Rehabilitation of Cancer Patients

Overview
Specialty Oncology
Date 1988 Jan 1
PMID 3415435
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Pathways of metabolic rehabilitation of cancer patients are discussed. The effectiveness of a long-term carbohydrate, fat and cholesterol restricted diet and hypolipidemic and antidiabetic medication for breast, gastric and colorectal cancers was demonstrated for the first time. The results of gastro-intestinal cancer treatment were especially encouraging. Metabolic rehabilitation chiefly resulted in a lower frequency of metastatic spread. Also, its effect was seen in a rarer primary multiple tumor development. The results make a case for further development of investigations in normalizing fat-carbohydrate metabolism as adjuvant therapy for cancer in postoperative period.

Citing Articles

Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.

Bojkova B, Kubatka P, Qaradakhi T, Zulli A, Kajo K Int J Mol Sci. 2018; 19(12).

PMID: 30563247 PMC: 6320927. DOI: 10.3390/ijms19123910.


Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption.

de Mey S, Jiang H, Corbet C, Wang H, Dufait I, Law K Front Pharmacol. 2018; 9:1073.

PMID: 30337872 PMC: 6178882. DOI: 10.3389/fphar.2018.01073.


Metformin for cancer and aging prevention: is it a time to make the long story short?.

Anisimov V Oncotarget. 2015; 6(37):39398-407.

PMID: 26583576 PMC: 4741834. DOI: 10.18632/oncotarget.6347.


Metformin, an old drug, brings a new era to cancer therapy.

He H, Ke R, Lin H, Ying Y, Liu D, Luo Z Cancer J. 2015; 21(2):70-4.

PMID: 25815846 PMC: 5588661. DOI: 10.1097/PPO.0000000000000103.


Do metformin a real anticarcinogen? A critical reappraisal of experimental data.

Anisimov V Ann Transl Med. 2014; 2(6):60.

PMID: 25333035 PMC: 4200660. DOI: 10.3978/j.issn.2305-5839.2014.06.02.